ClinVar Miner

Submissions for variant NM_000218.3(KCNQ1):c.1732+1G>T

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV004018241 SCV004848914 likely pathogenic Jervell and Lange-Nielsen syndrome 2023-02-02 criteria provided, single submitter clinical testing The c.1732+1G>T variant in KCNQ1 has not been previously reported in individuals with long QT syndrome or Jervell and Lange-Nielsen syndrome(JLNS) and was absent from large population studies. This variant occurs within the canonical splice site (+/- 1,2) and is predicted to cause altered splicing leading to an abnormal or absent protein. Another splice site variant (c.1732+2T>C impacting the same exon has been reported in an individual with long QT. Loss of function of the KCNQ1 gene is an established disease mechanism in autosomal dominant long QT and autosomal recessive JLNS. In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely pathogenic for autosomal dominant long QT and autosomal recessive Jervell and Lange-Nielsen syndrome. ACMG/AMP criteria applied: PVS1_Strong, PM2_Supporting.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.